FDA Accepts NDA for Paltusotine to Treat Adult Patients With Acromegaly
If approved, the treatment will be the first and only once-daily, oral selective somatostatin receptor type 2 nonpeptide agonist available for acromegaly.
If approved, the treatment will be the first and only once-daily, oral selective somatostatin receptor type 2 nonpeptide agonist available for acromegaly.
National Action Alliance for Patient and Workforce Safety Webinar announcement
AHRQ’s Healthcare-Associated Infections (HAI) Division funds clinical and health services research to develop the knowledge and practical tools used on the frontlines to prevent infections…
AHRQ Announces Interest in Research to Improve Treatment and Management of Menopause SymptomsAHRQ Announces Interest in Health Services Research to Improve Care Delivery, Access, Quality,…
FARAPULSE Pulsed Field Ablation is dedicated to transforming PFA, with more published clinical evidence than any other PFA system. Get the clinical data here.
With talent as a top strategic priority for Amgen, this program fits squarely into Amgen’s focus on developing a future-ready workforce with employees who represent…
AHRQ’s Healthcare-Associated Infections (HAI) Division funds clinical and health services research to develop the knowledge and practical tools used on the frontlines to prevent infections…
In this episode of Public Health Matters, Christina Madison discusses the concept of reproductive justice and ensuring Black maternal health efforts are not left behind…
National Action Alliance for Patient and Workforce Safety Webinar announcement
NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations and recognizes…
AHRQ Announces Interest in Research to Improve Treatment and Management of Menopause SymptomsAHRQ Announces Interest in Health Services Research to Improve Care Delivery, Access, Quality,…